Medpace is ready to help you with your next clinical trial project. Find out more about how we can help.

GO NOW

Effective Date: 7-FEB-2012

All Medpace employees, officers, and directors are held to the highest standards of ethical behavior in all business dealings and must fully comply with all applicable laws and with this Code. Honesty, confidentiality, integrity, and adherence to Medpace policies, standard operating procedures (SOPs) and applicable regulatory guidelines are our governing principles. All are held accountable for their actions and are required to report unethical or unlawful activities as well as any violations of this Code. Anyone who violates this Code is subject to disciplinary action, which may include termination of employment and/or legal action.

• The CEO, CFO, Compliance Officer, and all other members of the Medpace management team are responsible for working within their respective areas of responsibility to ensure that the Company operates in compliance with all applicable laws, rules, and regulations that govern the conduct of the company’s business worldwide. They are also responsible for promoting honest and ethical conduct including recognizing actual or potential conflicts of interest amongst themselves and others and for taking appropriate action to prevent collusion and inappropriate or unlawful financial transactions.
• All employees will work to ensure that financial information and all other public communications are reported completely, honestly, accurately, timely, and in an understandable manner.
• All employees are responsible for understanding and complying with all applicable company policies and SOPs.
• Open communication is encouraged throughout the organization.
• Confidential information should be disclosed only when authorized or required.
• The Board of Directors is responsible for considering any request for a waiver of or amendment to this code. Any waiver or amendment must receive a supermajority vote (at least 66%) of all directors for approval.
• Any violation of this Code or applicable law must be reported to the Corporate Compliance Officer or the Audit Committee of the Board of Directors.

Chair of the Audit Committee
Neil McCarthy, JD
Managing Director
Fairmount Partners
100 Four Falls Corporate Center
Suite 660
West Conshohocken, PA 19428
Tel: +1.610.260.6224
E-mail: neil.mccarthy@fairmountpartners.com

Corporate Compliance Officer
Stephen Ewald
General Counsel & Corporate Secretary
Medpace Corporate Headquarters
5375 Medpace Way
Cincinnati, Ohio 45227, USA
Office #3119
Tel: +1.513.579.9911, ext. 2055
Fax: +1.513.579.0444
E-mail: compliance@medpace.com